Tamai, H., Ida, Y., Kawashima, A., Shingaki, N., Shimizu, R., Moribata, K., . . . Kitano, M. (2017). Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus. Gut Liver.
Styl ChicagoTamai, Hideyuki, et al. "Simeprevir-Based Triple Therapy With Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients With Genotype 1b Hepatitis C Virus." Gut Liver 2017.
Citace podle MLATamai, Hideyuki, et al. "Simeprevir-Based Triple Therapy With Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients With Genotype 1b Hepatitis C Virus." Gut Liver 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..